{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:47:45Z","timestamp":1768812465199,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10549-020-05895-w","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T18:03:54Z","timestamp":1598465034000},"page":"763-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening women at high risk for breast cancer: one program fits all?"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0270-475X","authenticated-orcid":false,"given":"Naama","family":"Hermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Klil-Drori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Westergard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivianne","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabel","family":"Scaranelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"McCready","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin D.","family":"Cil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"351","key":"5895_CR1","doi-asserted-by":"publisher","first-page":"h4901","DOI":"10.1136\/bmj.h4901","volume":"6","author":"S Saadatmand","year":"2015","unstructured":"Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM (2015) Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients. BMJ 6(351):h4901","journal-title":"BMJ"},{"issue":"15","key":"5895_CR2","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.2015.13183","volume":"314","author":"ER Myers","year":"2015","unstructured":"Myers ER, Moorman P, Gierisch JM, Crowley MJ, McCrory DC, Kendrick A et al (2015) Benefits and harms of breast cancer screening: a systematic review. Jama 314(15):1615\u201334","journal-title":"Jama"},{"issue":"1_suppl","key":"5895_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1258\/jms.2012.012077","volume":"19","author":"E Paci","year":"2012","unstructured":"Paci E (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 19(1_suppl):5\u201313","journal-title":"J Med Screen"},{"issue":"1","key":"5895_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0969141316648987","volume":"24","author":"L Nystr\u00f6m","year":"2017","unstructured":"Nystr\u00f6m L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J (2017) Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malm\u00f6, Stockholm, and G\u00f6teborg. J Med Screen 24(1):34\u201342","journal-title":"J Med Screen"},{"issue":"3","key":"5895_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","volume":"15","author":"DL Monticciolo","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA (2018) Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3):408\u2013414","journal-title":"J Am Coll Radiol"},{"issue":"12","key":"5895_CR6","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","volume":"25","author":"RM Mann","year":"2015","unstructured":"Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women\u2019s information. Eur Radiol 25(12):3669\u20133678","journal-title":"Eur Radiol"},{"key":"5895_CR7","volume-title":"Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer","author":"National Collaborating Centre for Cancer (UK)","year":"2013","unstructured":"National Collaborating Centre for Cancer (UK) (2013) Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. National Collaborating Centre for Cancer (UK), Cardiff UK"},{"key":"5895_CR8","unstructured":"National Comprehensive Cancer Network, Breast Cancer Screening and Diagnosis (version 1.2019) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf. Accessed 2\/7\/2019"},{"key":"5895_CR9","unstructured":"Cancer Care Ontario, Ontario Breast Screening Program Information for Healthcare Providers; October 2015 https:\/\/www.cancercareontario.ca\/sites\/ccocancercare\/files\/assets\/OBSPHealthcareProviders.pdfAccessed 2\/7\/2019"},{"issue":"8","key":"5895_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/cncr.26424","volume":"118","author":"KP Lowry","year":"2012","unstructured":"Lowry KP, Lee JM, Kong CY et al (2012) Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer 118(8):2021\u20132030","journal-title":"Cancer"},{"issue":"1","key":"5895_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/bjc.2012.204","volume":"107","author":"K Passaperuma","year":"2012","unstructured":"Passaperuma K, Warner E, Causer PA et al (2012) Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer 107(1):24","journal-title":"Br J Cancer"},{"issue":"13","key":"5895_CR12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","volume":"29","author":"E Warner","year":"2011","unstructured":"Warner E, Hill K, Causer P et al (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29(13):1664","journal-title":"J Clin Oncol"},{"issue":"3","key":"5895_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10549-014-2931-9","volume":"145","author":"ED Gareth","year":"2014","unstructured":"Gareth ED, Nisha K, Yit L et al (2014) MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 145(3):663\u201372","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5895_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cncr.27771","volume":"119","author":"V Freitas","year":"2013","unstructured":"Freitas V, Scaranelo A, Menezes R, Kulkarni S, Hodgson D, Crystal P (2013) Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy. Cancer 119(3):495\u2013503","journal-title":"Cancer"},{"issue":"16","key":"5895_CR15","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/cncr.28747","volume":"120","author":"MT Tieu","year":"2014","unstructured":"Tieu MT, Cigsar C, Ahmed S et al (2014) Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer 120(16):2507\u20132513","journal-title":"Cancer"},{"key":"5895_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","volume":"20","author":"S Saadatmand","year":"2019","unstructured":"Saadatmand S, Geuzinge HA, Rutgers EJ et al (2019) MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol. 20:1136\u20131147","journal-title":"Lancet Oncol."},{"issue":"85","key":"5895_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.07.055","volume":"1","author":"XA Phi","year":"2017","unstructured":"Phi XA, Houssami N, Hooning MJ et al (2017) Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis. Eur J Cancer 1(85):31\u201338","journal-title":"Eur J Cancer"},{"issue":"1","key":"5895_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","volume":"175","author":"U Bick","year":"2019","unstructured":"Bick U, Engel C, Krug B et al (2019) High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 175(1):217\u2013228","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"5895_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9):1450\u20131457","journal-title":"J Clin Oncol"},{"issue":"3","key":"5895_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of K sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141\u20131154","journal-title":"Ann Stat"},{"key":"5895_CR21","doi-asserted-by":"crossref","unstructured":"Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2018. Toronto, ON: Canadian Cancer Society; June 2018. https:\/\/www.cancer.ca\/Canadian-Cancer-Statistics-2018-EN. Accessed 2\/7\/2019","DOI":"10.3322\/caac.21442"},{"issue":"10","key":"5895_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. JNCI 102(10):680\u201391","journal-title":"JNCI"},{"issue":"4","key":"5895_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","volume":"20","author":"MB Terry","year":"2019","unstructured":"Terry MB, Liao Y, Whittemore AS et al (2019) 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol 20(4):504\u2013517","journal-title":"Lancet Oncol"},{"issue":"9","key":"5895_CR24","doi-asserted-by":"publisher","first-page":"e180174","DOI":"10.1001\/jamaoncol.2018.0174","volume":"4","author":"AR Brentnall","year":"2018","unstructured":"Brentnall AR, Cuzick J, Buist DS, Bowles EJ (2018) Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol 4(9):e180174","journal-title":"JAMA Oncol"},{"issue":"1","key":"5895_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41416-018-0120-z","volume":"119","author":"LL Lo","year":"2018","unstructured":"Lo LL, Milne RL, Liao Y, Cuzick J, Terry MB, Phillips KA (2018) Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ. Br J Cancer 119(1):36","journal-title":"Br J Cancer"},{"issue":"1","key":"5895_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","volume":"3","author":"TS Menes","year":"2017","unstructured":"Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL (2017) Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy. JAMA Oncol 3(1):36\u201341","journal-title":"JAMA Oncol"},{"issue":"7","key":"5895_CR27","doi-asserted-by":"publisher","first-page":"djv124","DOI":"10.1093\/jnci\/djv124","volume":"107","author":"AS Quante","year":"2015","unstructured":"Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB (2015) Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst. 107(7):djv124. https:\/\/doi.org\/10.1093\/jnci\/djv124","journal-title":"J Natl Cancer Inst."},{"key":"5895_CR28","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Table 1.11 Median Age of Cancer Patients at Diagnosis, 2012\u20132016. https:\/\/seer.cancer.gov\/csr\/1975_2016\/results_single\/sect_01_table.11_2pgs.pdf#search=median%2520age%2520at%2520diagnosis. Accessed 2\/7\/2019"},{"key":"5895_CR29","unstructured":"National Comprehensive Cancer Network, Breast Cancer (version 3.2020) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf Accessed 20\/3\/20"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05895-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T03:48:41Z","timestamp":1668052121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05895-w"}},"subtitle":["Subgroup analysis of a large population high risk breast screening program"],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5895"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05895-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}